首页> 美国卫生研究院文献>Seminars in Interventional Radiology >Decision Making as a Growth Mechanism in Interventional Oncology: Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer—Y90 and Chemoembolization
【2h】

Decision Making as a Growth Mechanism in Interventional Oncology: Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer—Y90 and Chemoembolization

机译:决策作为介入肿瘤学的增长机制:介入肿瘤决策:转移性结直肠癌-Y90和化学栓塞的动脉内治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Colorectal cancer is the third most common cancer in the United States and the liver is the most common site of metastatic disease. The presence and extent of hepatic metastases are a major prognostic indicator. Although surgical resection is the accepted first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are eligible for resection due to the extent and location of disease. This article discusses the current role of transarterial therapies in the treatment of colorectal liver metastases.
机译:结直肠癌是美国第三大最常见的癌症,肝脏是最常见的转移性疾病部位。肝转移的存在和程度是主要的预后指标。尽管手术切除是结直肠肝转移的一线治疗方法,但由于疾病的程度和位置,只有20%到25%的患者可以切除。本文讨论经动脉疗法在大肠肝转移治疗中的当前作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号